Trade Summary

6 days ago, Xu Zhenyu, serving as Chief Scientific Officer at SOPHiA GENETICS SA (SOPH), sold 20,000 shares at $7.25 per share, for a total transaction value of $144,923.80. Following this transaction, Xu Zhenyu now holds 590,887 shares of SOPH.

This sale represents a 3.27% decrease in Xu Zhenyu's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, August 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 5:35 PM ET, 2 days after the trade was made.

SOPHiA GENETICS SA operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.